Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: Utility of transmitochondrial cybrids

Annals of the New York Academy of Sciences

Volumn 1201, Issue , 2010, Pages 137-146

  Kaipparettu, Benny Abraham ^a   Ma, Yewei ^a   Wong, Lee Jun C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cancer mitochondria: altered mitochondria in breast cancer; dual genome cross talk; transmitochondrial cybrid

Indexed keywords

BREAST CANCER; CANCER CELL CULTURE; CANCER RISK; CARCINOGENESIS; CELL ACTIVITY; CELL STRAIN LNCAP; CELL VIABILITY; CHROMOSOMAL INSTABILITY; CONFERENCE PAPER; CYBRID; DNA EXTRACTION; ENERGY METABOLISM; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC CODE; GLIOMA; HELA CELL; HUMAN; HUMAN CELL; LUNG CANCER; MELANOMA; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; OXIDATIVE PHOSPHORYLATION; PROSTATE CANCER; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NEOPLASM; REVIEW; RISK; TUMOR CELL LINE;

MITOCHONDRIAL DNA;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; ENERGY METABOLISM; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; RISK;

EID: 77955299384     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05621.x     Document Type: Conference Paper

References (63)

1. Smeitink, J., L. Van Den Heuvel & S. DiMauro. 2001. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet . 2: 342-352.
2. Wallace, D.C. 1999. Mitochondrial diseases in man and mouse. Science. 283: 1482-1488.
3. Dimmock, D.P. et al. 2008. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat. 29: 330-331.
4. Wong, L.J. et al. 2007. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology. 46: 1218-1227.
5. Augenlicht, L.H. & B.G. Heerdt. 2001. Mitochondria: integrators in tumorigenesis? Nat Genet . 28: 104-105.
6. Dasgupta, S. et al. 2008. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res. 68: 700-706.
7. Ishikawa,K. et al. 2008.ROS-generating mitochondrialDNA mutations can regulate tumor cell metastasis. Science. 320: 661-664.
8. Sasaki, R. et al. 2008. DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Cancer Sci. 99: 1040-1048.
9. Alonso, A. et al. 1997. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis. 18: 682-685.
10. Copeland,W.C. et al. 2002. Mitochondrial DNA alterations in cancer. Cancer Invest. 20: 557-569.
11. Fliss, M.S. et al. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 287: 2017-2019.
12. Habano, W. et al. 1999. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int. J. Cancer. 83: 625-629.
13. Hibi, K. et al. 2001. Mitochondrial DNA alteration in esophageal cancer. Int. J. Cancer. 92: 319-321.
14. Kirches, E. et al. 2001. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int. J. Cancer. 93: 534-538.
15. Kurtz, A. et al. 2004. SomaticmitochondrialDNAmutations in neurofibromatosis type 1-associated tumors. Mol. Cancer Res. 2: 433-441.
16. Liu, V.W. et al. 2001. High incidence of somatic mitochondrial DNAmutations in human ovarian carcinomas. Cancer Res. 61: 5998-6001.
17. Polyak, K. et al. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet . 20: 291-293.
18. Tamura, G. et al. 1999. Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur. J. Cancer. 35: 316-319.
19. Tan, D.J., R.K. Bai & L.J.Wong. 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62: 972-976.
20. Tan,D.J. et al. 2003.Novel heteroplasmic frameshift andmissense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer. 37: 186-194.
21. Tan, D.J. et al. 2006. Significance of somatic mutations and content alteration ofmitochondrialDNA in esophageal cancer. BMC Cancer. 6: 93.
22. Wong, L.J. et al. 2003. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 63: 3866-3871.
23. Wong, L.J. et al. 2004. Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J. Med. Genet . 41: e65.
24. Yeh, J.J. et al. 2000. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19: 2060-2066.
25. Brandon, M., P. Baldi & D.C. Wallace. 2006. Mitochondrial mutations in cancer. Oncogene 25: 4647-4662.
26. Astuti, D. et al. 2001. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet . 69: 49-54.
27. Baysal, B.E. et al. 2000.Mutations inSDHD, amitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851.
28. Gottlieb, E. & I.P. Tomlinson. 2005. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer. 5: 857-866.
29. Niemann, S. & U. Muller. 2000. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet . 26: 268-270.
30. Selak, M.A. et al. 2005. Succinate linksTCAcycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 7: 77-85.
31. Taschner, P.E. et al. 2001. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer. 31: 274-281.
32. Schofield, C.J. & P.J. Ratcliffe. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5: 343-354.
33. King, A., M.A. Selak & E. Gottlieb. 2006. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-4682.
34. King,M.P. & G. Attardi. 1989. Human cells lacking mtDNA: repopulation with exogenousmitochondria by complementation. Science. 246: 500-503.
35. Arnold, R.S. et al. 2009.MitochondrialDNAmutation stimulates prostate cancer growth in bone stromal environment. Prostate. 69: 1-11.
36. Bonora, E. et al. 2006. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associatedwith pathogenic mitochondrialDNAmutations affecting complexes I and III. Cancer Res. 66: 6087-6096.
37. Ma, Y. et al. 2010. Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim. Biophys. Acta. 1797: 29-37.
38. Petros, J.A. et al. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA 102: 719-724.
39. Shidara, Y. et al. 2005. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 65: 1655-1663.
40. Antonicka, H. et al. 1999. Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ('MERRF') at position 8344 nt. Biochem J . 342(Pt 3): 537-544.
41. Chomyn, A. et al. 1992. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstreammature transcripts. Proc. Natl. Acad. Sci. USA 89: 4221-4225.
42. Trounce, I., S. Neill & D.C. Wallace. 1994. Cytoplasmic transfer of the mtDNA nt 8993 T→G (ATP6) pointmutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregationwith a decrease in state III respiration and ADP/Oratio. Proc.Natl. Acad. Sci.USA 91: 8334-8338.
43. Ghelli, A. et al. 2003. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrialdependent apoptotic death in transmitochondrial cells incubatedwith galactosemedium. J. Biol.Chem. 278: 4145-4150.
44. Ishikawa, K. et al. 2008. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis. FEBS Lett . 582: 3525-3530.
45. Mineri, R. et al. 2009. How do human cells react to the absence of mitochondrial DNA? PLoS One. 4: e5713.
46. Magda, D. et al. 2008. mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft. BMC Genom. 9: 521.
47. Hayashi, J., M. Takemitsu & I. Nonaka. 1992. Recovery of themissing tumorigenicity inmitochondrialDNA-lessHeLa cells by introduction of mitochondrial DNA from normal human cells. Somat. Cell Mol. Genet . 18: 123-129.
48. Cavalli, L.R., M. Varella-Garcia & B.C. Liang. 1997. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ. 8: 1189-1198.
49. Yen, H.C. et al. 2005. Enhancement of cisplatin-induced apoptosis and caspase 3 activation by depletion of mitochondrial DNA in a human osteosarcoma cell line. Ann. N.Y. Acad Sci. 1042: 516-522.
50. Yamazaki, H. et al. 2008. Impact of mitochondrial DNA on hypoxic radiation sensitivity in human fibroblast cells and osteosarcoma cell lines. Oncol Rep. 19: 1545-1549.
51. Amuthan, G. et al. 2002. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene. 21: 7839-7849.
52. Ballot,C. et al. 2010. Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D. Apoptosis [Epub ahead of print].
53. Kulawiec, M. et al. 2008. Tumorigenic transformation of humanbreast epithelial cells induced by mitochondrialDNA depletion. Cancer Biol Ther. 7: 1732-1743.
54. Naito, A. et al. 2008. Induction of acquired resistance to antiestrogen by reversible mitochondrial DNA depletion in breast cancer cell line. Int J Cancer. 122: 1506-1511.
55. Singh, K.K. et al. 2005. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene. 354: 140-146.
56. Zhang, J. et al. 2009. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 40: 135-146.
57. Delsite, R. et al. 2002. Nuclear genes involved in mitochondria-to- nucleus communication in breast cancer cells. Mol Cancer. 1: 6.
58. Bai, R.K. et al. 2007. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 67: 4687-4694.
59. Covarrubias, D. et al. 2008. Mitochondrial DNA variant interactions modify breast cancer risk. J. Hum. Genet . 53: 924-928.
60. Canter, J.A. et al. 2005.Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65: 8028-8033.
61. Darvishi, K. et al. 2007.MitochondrialDNA G10398A polymorphism impartsmaternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett . 249: 249-255.
62. Kulawiec, M., K.M. Owens & K.K. Singh. 2009. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J. Hum. Genet . 54: 647-654.
63. Naito, A. et al. 2008. Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA-depleted cells. Cancer Sci. 99: 1584-1588.